导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.84% | 3285/4773 |
| 近一周 | -1.03% | 1546/5465 |
| 近一月 | -8.51% | 4967/5421 |
| 近一季 | -4.62% | 1853/5231 |
| 近半年 | -7.52% | 3361/4920 |
| 近一年 | -1.24% | 2944/4394 |
| 近两年 | 111.00% | 521/2954 |
| 近三年 | 65.23% | 406/2253 |
| 成立以来 | 39.32% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.92% 2969/4961 |
6.57% 2819/5312 |
- - |
- - |
| 2025 | 49.88% 474/4813 |
7.12% 521/3635 |
0.95% 2520/4076 |
37.35% 917/4524 |
0.90% 1676/4813 |
| 2024 | 19.01% 564/3463 |
-1.77% 1274/2808 |
-6.67% 1994/3014 |
18.53% 995/3129 |
9.53% 323/3463 |
| 2023 | 15.16% 38/2656 |
45.82% 13/2280 |
2.42% 145/2385 |
-18.30% 2328/2515 |
-5.62% 1427/2655 |
| 2022 | -21.09% 1008/2207 |
-20.70% 1565/1919 |
-3.28% 1808/2016 |
-12.05% 632/2113 |
16.97% 52/2208 |
| 2021 | -9.98% 1088/1822 |
-12.55% 1149/1255 |
6.79% 719/1330 |
-5.58% 828/1466 |
2.09% 701/1822 |
| 2020 | 51.06% 161/1250 |
-1.34% 214/1028 |
11.36% 736/1067 |
28.94% 15/1164 |
6.64% 751/1184 |
| 2019 | 23.04% 638/1092 |
31.01% 217/754 |
-8.52% 597/804 |
3.87% 229/850 |
-1.17% 896/918 |
| 2018 | -27.65% 426/834 |
- - |
- - |
- - |
-12.78% 483/691 |
| 2017 | -16.07% 567/714 |
- - |
- - |
- - |
- - |
| 2016 | -22.82% 462/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 融通中证云计算与大数据主题指数(LOF)A VS. 长安沪深300非周期A(740101) |